Biora Therapeutics, Inc. (NASDAQ:BIOR – Get Free Report) shares dropped 2.2% during trading on Friday . The company traded as low as $0.14 and last traded at $0.14. Approximately 1,973 shares were traded during trading, a decline of 97% from the average daily volume of 70,028 shares. The stock had previously closed at $0.14.
Biora Therapeutics Stock Performance
The stock has a market capitalization of $612,866.50, a P/E ratio of -0.01 and a beta of 1.12. The stock has a 50 day moving average of $0.14 and a 200 day moving average of $0.49.
About Biora Therapeutics
Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.
Recommended Stories
- Five stocks we like better than Biora Therapeutics
- Business Services Stocks Investing
- Pfizer’s 7.5% Dividend: Income Haven or House of Cards?
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 Trades Members of Congress Are Making Right Now
- Buy P&G Now, Before It Sets A New All-Time High
- TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain
Receive News & Ratings for Biora Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biora Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
